Background: Astaxanthin (AX) has been attributed with extraordinary potential for protecting the organism against different types of cancer due to its anti-oxidant activity. Also pre-clinical cell culture and animal model studies suggest promise of certain naturally occurring vitamin E (i.e. α-tocopherol) as anticancer agents. We assessed the effect of AX and α-tocopherol (AT) respectively and double combination on human esophageal cancer cell lines to show the mechanism of anticancer effect and its therapeutic potential. Material and Method: Two human esophageal cancer cell lines (TE-1, TE-4) were exposed to AX(6 to 10 μg/mL) and AT(20 to 100 μM) for 24 hours. Quantification of proliferation was performed by MTT assay. Cell cycle machinery proteins such as AKT, p-p38, cyclin D1 (cell proliferation), p27 (cell apoptosis) and Caspase-3 (cell death) were investigated by Western blot. Result: Significant inhibition of cell proliferation of AX and AT was observed in TE-4 cell line by a dose-dependent manner, however AT shows no effect in TE-1 cell line. AX and AT as single agents increased the protein expression of p27 and caspase-3 in TE-4 cell line, however double combination didn't. Conclusion: AX and AT as single agents are effective at inhibition of cell proliferation and induce apoptosis by the modulation of cell cycle machinery proteins. However, our data could not suggest that 2-drug combination has any cooperative inhibitory effect on the growth of esophageal cancer cells.
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